Benzinga | Oct 21, 2021 12:11PM EDT

SVB Leerink Maintains Market Perform on Abbott Laboratories, Raises Price Target to $140

SVB Leerink analyst Danielle Antalffy maintains Abbott Laboratories (NYSE:ABT) with a Market Perform and raises the price target from $128 to $140.